Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this research study is to assess whether the participant's disease,
Myelodysplastic Syndromes (MDS), responds favorably to INCB024360. The study will also
evaluate the long-term outcomes of the participant's disease after they have finished taking
INCB024360.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute